4//SEC Filing
Hawi Amale 4
Accession 0001209191-10-047267
CIK 0001047188other
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 4:10 PM ET
Size
14.4 KB
Accession
0001209191-10-047267
Insider Transaction Report
Form 4
Hawi Amale
SVP, Pharmaceutical Dev.
Transactions
- Disposition from Tender
Common Stock
2010-09-20−6,500→ 0 total - Disposition from Tender
Stock Option (Right-to-Buy)
2010-09-20$3.05/sh−15,000$45,750→ 0 totalExercise: $3.05Exp: 2018-06-11→ Common Stock (15,000 underlying) - Disposition from Tender
Stock Option (Right-to-Buy)
2010-09-20$2.62/sh−35,000$91,700→ 0 totalExercise: $2.62Exp: 2018-03-13→ Common Stock (35,000 underlying) - Disposition from Tender
Stock Option (Right-to-Buy)
2010-09-20$1.56/sh−65,000$101,400→ 0 totalExercise: $1.56Exp: 2019-03-05→ Common Stock (65,000 underlying) - Disposition from Tender
Stock Option (Right-to-Buy)
2010-09-20$3.04/sh−75,000$228,000→ 0 totalExercise: $3.04Exp: 2020-03-05→ Common Stock (75,000 underlying)
Footnotes (4)
- [F1]Reflects shares of common stock that were tendered in a tender offer by West Acquisition Corp. for consideration of $5.00 per share in cash.
- [F2]The option became fully vested on June 30, 2010.
- [F3]Disposed of by conditional exercise and tender in a tender offer by West Acquisition Corp. for consideration of $5.00 in cash per share issuable upon the exercise of such option, less an amount equal to the exercise price of such option
- [F4]The option became fully vested on September 20, 2010.
Documents
Issuer
PENWEST PHARMACEUTICALS CO
CIK 0001047188
Entity typeother
Related Parties
1- filerCIK 0001397456
Filing Metadata
- Form type
- 4
- Filed
- Sep 21, 8:00 PM ET
- Accepted
- Sep 22, 4:10 PM ET
- Size
- 14.4 KB